What's new

EMEA-003149-PIP01-21-M02

EMEA-003149-PIP01-21-M02

Mar 19, 2025 - 12:47
 0
EMEA-003149-PIP01-21-M02
EMEA-003149-PIP01-21-M02
Read More

Tags:

Previous Article

STAT+: Immunovant and Roivant report success in autoimmune drug’s Phase 3 trial

Next Article

Self-checkout boycott drives change at Britain retailers

Related Posts

Human medicines European public assessment report (EPAR): Viagra, sildenafil, Date of authorisation: 13/09/1998, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 14, 2025  0

Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0